Schizophrenia Research Study
Researchers at Arch Clinical Trials are conducting a study on an investigational drug treatment for adults with schizophrenia.
Fast Facts
Diagnosed with schizophrenia for ≥1 year
18-65
Years Old
Compensation
Provided
Conducted in
St. Louis, MO
Study Background
This study is evaluating the long-term safety of an investigational medication for adults with schizophrenia.
Schizophrenia is a long-term mental health condition that can affect the way people think, feel, and behave. Current treatments can be effective, but many patients experience ongoing symptoms, side effects, or challenges staying on medication. Research is needed to explore investigational treatment options that may better support individuals living with this condition.
In this study, participants will transition from their current antipsychotic medication to the study drug. Over a period of up to three years, researchers will monitor participants’ health and wellbeing through regular visits, medical assessments, and questionnaires. The goal is to better understand the safety of this medication over time, and to help identify a future treatment option for people living with schizophrenia.
Study Background
This study is evaluating the long-term safety of an investigational medication for adults with schizophrenia.
Schizophrenia is a long-term mental health condition that can affect the way people think, feel, and behave. Current treatments can be effective, but many patients experience ongoing symptoms, side effects, or challenges staying on medication. Research is needed to explore investigational treatment options that may better support individuals living with this condition.
In this study, participants will transition from their current antipsychotic medication to the study drug. Over a period of up to three years, researchers will monitor participants’ health and wellbeing through regular visits, medical assessments, and questionnaires. The goal is to better understand the safety of this medication over time, and to help identify a future treatment option for people living with schizophrenia.
Additional Information
This study is being done to evaluate the long-term safety of the study drug in adults with schizophrenia.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
- Diagnosed with schizophrenia for ≥1 year
- Ages 18-65
- Not pregnant, breastfeeding, or planning to become pregnant in near future
If you qualify and choose to participate, here’s what you can expect:
- Screening – You’ll first complete a phone interview and then visit the clinic for screening. This includes reviewing your medical and psychiatric history, physical exam, blood and urine tests, and questionnaires to confirm eligibility.
- Stopping current medication – Before starting the study drug, you will stop taking any restricted antipsychotic medication under the supervision of the study doctor.
- Starting the study drug – You’ll receive your first dose of the study medication.
- Study visits –
During the first year, you’ll have visits every 2 weeks (a mix of in-person and remote).
In years 2 and 3, you’ll have in-person visits every 3 months.
Assessments at visits – At each visit, you may have your vital signs, heart activity (ECG), blood and urine samples, interviews, and questionnaires checked.
Compensation provided. Snacks, coffee, and meals may be provided during study visits. We may also be able to offer transportation to and from the study site to make participation easier.
There is no cost for you to participate in our research study.